GATA2 and primary lymphedema: Moreover, 2 recurrent mutations that cause reduced GATA2 expression (c.1017+512del28 and c.1017+572C>T) within a highly conserved 167-bp intragenic enhancer of intron 5 of GATA2 have been found in patients with primary lymphedema (20–22).